Acasti Pharma Inc.
ACST
$3.32
-$0.04-1.19%
| 12/31/2023 | 09/30/2023 | 06/30/2023 | 03/31/2023 | 12/31/2022 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | 1.60M | 1.63M | 1.87M | 2.53M | 1.80M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 3.04M | 2.09M | 2.96M | 4.16M | 4.25M |
| Operating Income | -3.04M | -2.09M | -2.96M | -4.16M | -4.25M |
| Income Before Tax | -2.60M | -3.72M | -4.31M | -37.96M | -4.16M |
| Income Tax Expenses | -208.00K | -446.00K | -289.00K | -8.87M | -274.00K |
| Earnings from Continuing Operations | -2.39M | -3.27M | -4.02M | -29.09M | -3.89M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -2.39M | -3.27M | -4.02M | -29.09M | -3.89M |
| EBIT | -3.04M | -2.09M | -2.96M | -4.16M | -4.25M |
| EBITDA | -3.04M | -2.09M | -2.95M | -4.15M | -4.24M |
| EPS Basic | -0.21 | -0.43 | -0.54 | -3.88 | -0.52 |
| Normalized Basic EPS | -0.14 | -0.31 | -0.24 | -0.34 | -0.35 |
| EPS Diluted | -0.21 | -0.43 | -0.54 | -3.88 | -0.52 |
| Normalized Diluted EPS | -0.14 | -0.31 | -0.24 | -0.34 | -0.35 |
| Average Basic Shares Outstanding | 11.51M | 7.55M | 7.44M | 7.49M | 7.44M |
| Average Diluted Shares Outstanding | 11.51M | 7.55M | 7.44M | 7.49M | 7.44M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |
